IBDEI13E ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18239,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,18239,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,18240,0)
 ;;=M34.82^^94^905^276
 ;;^UTILITY(U,$J,358.3,18240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18240,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,18240,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,18240,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,18241,0)
 ;;=M34.83^^94^905^277
 ;;^UTILITY(U,$J,358.3,18241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18241,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18241,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,18241,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,18242,0)
 ;;=M34.89^^94^905^274
 ;;^UTILITY(U,$J,358.3,18242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18242,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,18242,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,18242,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,18243,0)
 ;;=M34.9^^94^905^278
 ;;^UTILITY(U,$J,358.3,18243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18243,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,18243,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,18243,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,18244,0)
 ;;=R21.^^94^905^257
 ;;^UTILITY(U,$J,358.3,18244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18244,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,18244,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,18244,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,18245,0)
 ;;=R23.3^^94^905^269
 ;;^UTILITY(U,$J,358.3,18245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18245,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,18245,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,18245,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,18246,0)
 ;;=L03.113^^94^905^112
 ;;^UTILITY(U,$J,358.3,18246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18246,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,18246,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,18246,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,18247,0)
 ;;=L03.114^^94^905^105
 ;;^UTILITY(U,$J,358.3,18247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18247,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,18247,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,18247,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,18248,0)
 ;;=L03.115^^94^905^109
 ;;^UTILITY(U,$J,358.3,18248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18248,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,18248,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,18248,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,18249,0)
 ;;=L03.116^^94^905^102
 ;;^UTILITY(U,$J,358.3,18249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18249,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,18249,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,18249,2)
 ;;=^5133645
 ;;^UTILITY(U,$J,358.3,18250,0)
 ;;=L03.123^^94^905^27
 ;;^UTILITY(U,$J,358.3,18250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18250,1,3,0)
 ;;=3^Acute Lymphangitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,18250,1,4,0)
 ;;=4^L03.123
 ;;^UTILITY(U,$J,358.3,18250,2)
 ;;=^5009039
 ;;^UTILITY(U,$J,358.3,18251,0)
 ;;=L03.124^^94^905^21
 ;;^UTILITY(U,$J,358.3,18251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18251,1,3,0)
 ;;=3^Acute Lymphangitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,18251,1,4,0)
 ;;=4^L03.124
 ;;^UTILITY(U,$J,358.3,18251,2)
 ;;=^5009040
 ;;^UTILITY(U,$J,358.3,18252,0)
 ;;=L03.125^^94^905^25
 ;;^UTILITY(U,$J,358.3,18252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18252,1,3,0)
 ;;=3^Acute Lymphangitis of Right Lower Limb
